Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Nature Chemical Biology
|
February 5, 2026
A pharmacological modality to sequester homomeric proteins
Ella Livnah, Ohad Suss, Adi Rogel, et al.
Journal of the American Chemical Society
|
February 4, 2023
Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry
Rambabu N Reddi, Adi Rogel, Ronen Gabizon, et al.
Research Square
|
February 24, 2025
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
Frank von Delft, Xiaomin Ni, R Richardson, et al.
The Journal of Clinical Investigation
|
May 20, 2021
Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine
Ofer Beharier, Romina Plitman Mayo, Tal Raz, et al.
Nature Genetics
|
October 31, 2020
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
Gabriela S Kinker, Alissa C Greenwald, Rotem Tal, et al.
The Journal of Clinical Investigation
|
October 1, 2021
Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine
Ofer Beharier, Romina Plitman Mayo, Tal Raz, et al.
Science Signaling
|
January 22, 2015
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
Nir Ben-Chetrit, David Chetrit, Roslin Russell, et al.
The Journal of Clinical Investigation
|
August 10, 2023
Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer's disease phenotype in mice
Nathaniel L Gould, Gila R Scherer, Silvia Carvalho, et al.
Biorxiv : the Preprint Server for Biology
|
May 15, 2024
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
Xiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 protease
Nathaniel T Kenton, Haim Barr, Artem Cherepakha, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Nature Chemical Biology
|
February 5, 2026
A pharmacological modality to sequester homomeric proteins
Ella Livnah, Ohad Suss, Adi Rogel, et al.
Journal of the American Chemical Society
|
February 4, 2023
Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry
Rambabu N Reddi, Adi Rogel, Ronen Gabizon, et al.
Research Square
|
February 24, 2025
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
Frank von Delft, Xiaomin Ni, R Richardson, et al.
The Journal of Clinical Investigation
|
May 20, 2021
Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine
Ofer Beharier, Romina Plitman Mayo, Tal Raz, et al.
Nature Genetics
|
October 31, 2020
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
Gabriela S Kinker, Alissa C Greenwald, Rotem Tal, et al.
The Journal of Clinical Investigation
|
October 1, 2021
Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine
Ofer Beharier, Romina Plitman Mayo, Tal Raz, et al.
Science Signaling
|
January 22, 2015
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
Nir Ben-Chetrit, David Chetrit, Roslin Russell, et al.
The Journal of Clinical Investigation
|
August 10, 2023
Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer's disease phenotype in mice
Nathaniel L Gould, Gila R Scherer, Silvia Carvalho, et al.
Biorxiv : the Preprint Server for Biology
|
May 15, 2024
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
Xiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 protease
Nathaniel T Kenton, Haim Barr, Artem Cherepakha, et al.
Page
of 4